Skip to main content

Table 1 The case numbers and incidence rates of kidney cancer between 1990 and 2030 at the global level

From: Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study

 199020172030AAPC (95% CI) of ASR
No. of cases
(× 1000)
ASR
(/100,000)
No. of cases
(×1000)
ASR
(/100,000)
No. of cases (×1000)
(95% HDI)
ASR (/100,000)
(95% HDI)
1990–20172018–2030
Overall207.34.72393.04.94475.4 (423.9, 526.9)4.46 (4.06, 4.86)0.14 (0.08, 0.20)*−0.97 (−0.99, −0.95) *
Sex
 Male114.65.65240.86.38298.1 (270.7, 325.6)5.81 (5.29, 6.32)0.38 (0.30, 0.46)*−0.82 (−0.84, − 0.80)*
 Female92.73.96152.33.68187.4 (171.3, 203.4)3.39 (3.11, 3.67)−0.26 (− 0.30, − 0.23)*−0.73 (− 0.75, − 0.72)*
Age yearsa
 0–1927.024.418.4 (15.5, 21.4)
 20–3917.023.321.7 (19.7, 23.7)
 40–6490.3171.5189.6 (172.5, 206.7)
 65+73.0173.8248.8 (226.4, 271.3)
  1. ASR Age-standardized incidence rate, AAPC Average annual percentage change, CI Confidence interval, HDI Highest density interval
  2. a, for each age group, only the number of cancer cases is shown because the ASR was not available when the age was grouped
  3. *, P < 0.001